Vasopressins

• 

  Subject Areas on Research

  • A fluorescent assay for agonist-activated phospholipase D in mammalian cell extracts. 
  • Abnormal osmotic regulation in trpv4-/- mice. 
  • Abnormal water metabolism in mice lacking the type 1A receptor for ANG II. 
  • Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2. 
  • Binding of 3H-phenamil, an irreversible amiloride analog, to toad urinary bladder: effects of aldosterone and vasopressin. 
  • Characterization of purified endosomes containing the antidiuretic hormone-sensitive water channel from rat renal papilla. 
  • Cloning of an aquaporin homologue present in water channel containing endosomes of toad urinary bladder. 
  • Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure. 
  • Cyclosporine augments receptor-mediated cellular Ca2+ fluxes in isolated hepatocytes. 
  • Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. 
  • Dominant factors that govern pressure natriuresis in diuresis and antidiuresis: a mathematical model. 
  • Effect of pharmacologic increases in afterload on left ventricular rotation and strain in a rabbit model. 
  • Effect of vasopressin and serosal hypertonicity on toad urinary bladder. 
  • Effects of acupuncture on vasopressin-induced emesis in conscious dogs. 
  • Effects of colchicine and cytochalasin B on vasopressin- and cyclic adenosine monophosphate-induced changes in toad urinary bladder. 
  • Effects of electroconvulsive therapy on plasma vasopressin and oxytocin. 
  • Effects of triiodothyronine and vasopressin on cardiac function and myocardial blood flow after brain death. 
  • Emergency portacaval shunts: is Orloff correct? 
  • Enhanced central response to dehydration in mice lacking angiotensin AT(1a) receptors. 
  • Evaluation of three acute tests of hypothalamic-pituitary-adrenal function. 
  • Fate of antidiuretic hormone water channel proteins after retrieval from apical membrane. 
  • Forskolin stimulates phosphorylation and membrane accumulation of UT-A3. 
  • Galphaq-dependent signaling cascades stimulate water-seeking behavior. 
  • Glucagon-induced desensitization of adenylyl cyclase in primary cultures of chick hepatocytes. Evidence for multiple pathways. 
  • Glycogenolytic effects of the calcium ionophore A23187, but not of vasopressin or angiotensin, in foetal-rat hepatocytes. 
  • Hyponatremia treatment guidelines 2007: expert panel recommendations. 
  • Inappropriate antidiuretic hormone secretion. Occurrence in a patient with Rocky Mountain spotted fever. 
  • Inhibitory action of a new sympathomimetic amino (DU-21220) on the nongravid uterus. 
  • Inhibitory effects of DuP 753 and EXP3174 on responses to angiotensin II in pulmonary vascular bed of the cat. 
  • Introduction: Vasopressin therapy. 
  • Magnesium-calcium antagonism in the contraction of arterioles. 
  • Magnetic resonance imaging of guinea pig cochlea after vasopressin-induced or surgically induced endolymphatic hydrops. 
  • Modulation of vasopressin-elicited water transport by trafficking of aquaporin2-containing vesicles. 
  • Neonatal sympathectomy compromises development of responses of ornithine decarboxylase to hormonal stimulation in peripheral tissues. 
  • Neuroendocrine effects of dehydration in mice lacking the angiotensin AT1a receptor. 
  • Pain sensitivity and vasopressin analgesia are mediated by a gene-sex-environment interaction. 
  • Pathophysiology of experimental renovascular hypertension. 
  • Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. 
  • Pro: Vasopressin is the vasoconstrictor of choice after cardiopulmonary bypass. 
  • Psychoneuroendocrinology of schizophrenia. 
  • Re: Nonlocalized lower gastrointestinal bleeding: provocative bleeding studies with intraarterial tPA, heparin, and tolazoline. 
  • Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial. 
  • Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney Goldblatt hypertension. 
  • Relax, you won't feel the pain. 
  • Relaxant effect of diazepam on uterine muscle. 
  • Responsiveness of atrial natriuretic factor to reduction in right atrial pressure in patients with chronic congestive heart failure. 
  • Selective adjustment of the speed of internal clock and memory processes. 
  • Sodium and water regulation in a patient with cerebral salt wasting. 
  • Structural and functional response of toad urinary bladder to LiCl. 
  • Syndrome of inappropriate secretion of antidiuretic hormone in a patient with carcinoma of the nasopharynx. 
  • Syndrome of inappropriate secretion of antidiuretic hormone in a patient with carcinoma of the nasopharynx. 
  • The action of alpha-adrenergic agonists on plasma-membrane calcium fluxes in perfused rat liver. 
  • The effect of ethyl alcohol on isolated human myometrium. 
  • The in vitro reversal of histamine-induced vasodilation in the human internal mammary artery. 
  • The physiology of urinary concentration: an update. 
  • The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation. 
  • Time course of vasopressin-induced formation of microvilli in granular cells of toad university bladder. 
  • Toxic effects of catecholamines on skin. 
  • Urinary vasopressin and aldosterone and plasma volume during a saturation dive to 450 m. 
  • Vasopressin and the Neurogenetics of Parental Care. 
  • Vasopressin for refractory hypotension in extremely low birth weight infants. 
  • Vasopressin receptor antagonists. 
  • Vasopressin-stimulated increase in phosphorylation at Ser269 potentiates plasma membrane retention of aquaporin-2. 
  • What's new in diuretic therapy. 
  • [Action of vasopressin on the luminal surface of the toad urinary bladder (proceedings)]